Evidence map›Paper›PMID 32328954›Full record

ReviewClinical reviews in allergy & immunology2020

Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice.

Guogang Xu, Yongshi Yang, Yingzhen Du, Fujun Peng, Peng Hu, Runsheng Wang, Ming Yin, Tianzhi Li, Lei Tu, Jinlyu Sun and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical reviews in allergy & immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Visual Modeling Languages in Patient Pathways: Scoping Review.Interactive journal of medical research · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Innovations and development of Covid-19 vaccines: A patent review.Journal of infection and public health · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Progression of the Pathway for Public Health Care during the COVID-19 Outbreak at District Health Office.International journal of environmental research and public health · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Guogang XuDepartment of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, 100853, China.
Yongshi YangDepartment of Allergy & Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
Yingzhen DuDepartment of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, 100853, China.
Fujun PengCenter for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 9, Dongdan 3rd, Dongcheng District, Beijing, 100005, China.
Peng HuDepartment of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, 100853, China.
Runsheng WangDepartment of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, 100853, China.
Ming YinDepartment of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, 100853, China.
Tianzhi LiDepartment of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, 100853, China.
Lei TuDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. tulei_1985@126.com.
Jinlyu SunDepartment of Allergy & Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Immunologic Diseases, No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China. sunjinlv@pumch.cn.
Taijiao JiangCenter for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 9, Dongdan 3rd, Dongcheng District, Beijing, 100005, China. taijiao@ibms.pumc.edu.cn.
Christopher ChangDivision of Pediatric Immunology and Allergy, Joe DiMaggio Children's Hospital, 1131 N 35th Avenue, Suite 220, Hollywood, FL, 33021, USA. chrchang@mhs.net.
Chinese PLA General Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSuzhou Institute of Systems Medicine · CNJoe DiMaggio Children's Hospital · USUnion Hospital · CN

Funding

Beijing Municipal Natural Science Foundation 7192197National Natural Science Foundation of China 31671371
6 · The paper itself

Abstract

The COVID-19 pandemic is a significant global event in the history of infectious diseases. The SARS-CoV-2 appears to have originated from bats but is now easily transmissible among humans, primarily through droplet or direct contact. Clinical features of COVID-19 include high fever, cough, and fatigue which may progress to ARDS. Respiratory failure can occur rapidly after this. The primary laboratory findings include lymphopenia and eosinopenia. Elevated D-dimer, procalcitonin, and CRP levels may correlate with disease severity. Imaging findings include ground-glass opacities and patchy consolidation on CT scan. Mortality is higher in patients with hypertension, cardiac disease, diabetes mellitus, cancer, and COPD. Elderly patients are more susceptible to severe disease and death, while children seem to have lower rates of infection and lower mortality. Diagnostic criteria and the identification of persons under investigation have evolved as more data has emerged. However, the approach to diagnosis is still very variable from region to region, country to country, and even among different hospitals in the same city. The importance of a clinical pathway to implement the most effective and relevant diagnostic strategy is of critical importance to establish the control of this virus that is responsible for more and more deaths each day.

Indexed as

AlgorithmsAntibodies, ViralBetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingCOVID-19 VaccinesCritical PathwaysEarly DiagnosisEvidence-Based PracticeFalse Negative ReactionsHumansImmunoglobulin GImmunoglobulin MLungAntibodies, ViralCovid-19 aAPC vaccineCOVID-19 VaccinesImmunoglobulin GImmunoglobulin MRNA, ViralAcute respiratory distress syndromeCDCClinical pathwayCoronavirusCOVID-19InfectionOutbreakPandemicPneumoniaQuarantineSARS-CoV-2TransmissionVirusWHO

Identifiers

PMID32328954
PMCPMC7180681
OpenAlexW3020166913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.